arrow
S

Suvi T. M. Orr

Pfizer
H指数:16
被引数:1,021

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of a potent and orally bioavailable reversible TEAD inhibitor (R)-3-(5-(1-methyl-3-((4-(trifluoromethyl)phenyl) amino)-1H-pyrazol-4-yl)-1,3,4-oxadiazol-2-yl)-3-vinylpyrrolidin-2-one

发现一种强效且口服生物利用度高的可逆TEAD抑制剂(R)-3-(5-(1-甲基-3-((4-(三氟甲基)苯基)氨基)-1H-吡唑-4-基)-1,3,4-噁二唑-2-基)-3-乙烯基吡咯烷-2-酮

2026-05-010
OAAI
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
2025-12-010
PRE
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety

CDK4选择性抑制提高了临床前抗肿瘤疗效和安全性

2025-03-011
OAAI
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)
2020-12-2426
PREAI
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
2017-03-2984
PREAI
Discovery of 1-{(3R,4R)-3[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
2016-01-2896
PREAI
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases
2015-10-2854
PREAI
Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment
2015-10-0638
OAAI
Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2)
2015-09-1568
PREAI
Evaluation and Synthesis of Polar Aryl- and Heteroaryl Spiroazetidine-Piperidine Acetamides as Ghrelin Inverse Agonists
2014-12-1916
OAAI
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate
2014-02-2463
OAAI
Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 Agonists

鉴定四氢吡啶并 [4,3-d] 嘧啶酰胺作为一类新的口服生物可利用的TGR5激动剂

2012-11-0947
OA